SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001047469-03-004936
Filing Date
2003-02-12
Accepted
2003-02-12 14:29:29
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A a2103012zsc13ga.htm SC 13G/A 79647
3 EXHIBIT-99.1 a2103012zex-99_1.htm EX-99.1 10797
  Complete submission text file 0001047469-03-004936.txt   92795
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address 995 EAST ARQUES AVE SUNNYVALE CA 94085 4087740330
PHARMACYCLICS INC (Subject) CIK: 0000949699 (see all company filings)

IRS No.: 943148201 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-49440 | Film No.: 03553880
SIC: 2834 Pharmaceutical Preparations